Wei Xu
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Bisrat G. DebebNaoto T. UenoWendy A. WoodwardTakeshi SudaGuisheng ZhangDexi LiuKenya KamimuraLara Lacerda
- Topics
- Cancer, Lipids, and Metabolism (13 papers)Hepatocellular Carcinoma Treatment and Prognosis (10 papers)Pancreatic and Hepatic Oncology Research (9 papers)
- Journals
- Angewandte Chemie International EditionSHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Xu
137 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 740
- Oncology 380
- Cancer Research 286
- Surgery 257
- Pulmonary and Respiratory Medicine 249
Countries citing papers authored by Wei Xu
This map shows the geographic impact of Wei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xu more than expected).
Fields of papers citing papers by Wei Xu
This network shows the impact of papers produced by Wei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xu. The network helps show where Wei Xu may publish in the future.
Co-authorship network of co-authors of Wei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xu. A scholar is included among the top collaborators of Wei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xu. Wei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 16 | |
| 10 | 12 | |
| 11 | 17 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 1 | |
| 15 | 30 | |
| 16 | 6 | |
| 17 | 10 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 41 |
About Wei Xu
Wei Xu is a scholar working on Cancer Research, Oncology and Hepatology, having authored 152 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). The work is most often cited by research in Cancer Research (286 citations), Oncology (380 citations) and Molecular Biology (740 citations). Wei Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Bisrat G. Debeb, Naoto T. Ueno, Wendy A. Woodward, Takeshi Suda, Guisheng Zhang, Dexi Liu, Kenya Kamimura, Lara Lacerda, Richard Larson and Jagadese J. Vittal. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.